91 matches.
- EventsOhio Hospital Association's 110th Annual Meeting & Education SummitMay 19–21, 20252 minute read
- EventsAMCP 2025: Understanding 340B Stakeholder Perspectives, Litigation Trends, and Reform Prospects2 minute read
- BlogsDEA Telemedicine Rules Further Delayed Until (Nearly) 20263 minute read
- BlogsEffective Dates of DEA Final Rules for Telemedicine Prescribing Delayed3 minute read
- BlogsThe 340B Reimbursement Battle: What Hospitals and Insurers Need to Know14 minute read
- BlogsAt Long Last, DEA’s Remote Prescribing Rules 2.0 Are (Really) Here! (Pending Further Consideration by the Incoming Administration . . .)18 minute read
- BlogsCMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 913 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 202514 minute read
- Firm AnnouncementsEpstein Becker Green Honored for Exceptional Performance in Key Practice Areas by Chambers USA 20245 minute read
- EventsAPhA2024: The Inflation Reduction Act - Implications for Pharmacy2 minute read
- Events340B Coalition Winter Conference 2024: Contract Pharmacy Deeper Dive1 minute read
- PublicationsHospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy11 minute read
- PublicationsIn Genesis Case, South Carolina District Court Scraps HRSA Interpretation of “Patient” Under 340B Statute9 minute read
- PublicationsState Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law25 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Recognized by 2024 Best Lawyers for Excellence in the Legal Profession12 minute read
- Firm AnnouncementsEpstein Becker Green Recognized for Focused Excellence Across Core Practice Areas in Chambers USA 20235 minute read
- BlogsMore Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate12 minute read
- PublicationsCMS’s Initial Guidance on Medicare Drug Price Negotiation Program Suggests Familiar Pharmacy Chargeback Process12 minute read
- BlogsThe Wait Is Over . . . Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways21 minute read
- EventsAmerican Society for Pharmacy Law: Trends in Drug Spending, Pricing, and Pharmacy Reimbursement2 minute read
- PublicationsCongressional Legislation Seeks to Ensure “Equitable Treatment” in the 340B Program2 minute read
- PublicationsMore Changes in Store for Pharmaceutical Supply Chain Following Passage of Inflation Reduction Act18 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Recognized by 2023 Best Lawyers for Excellence in the Legal Profession11 minute read
- Events340B Coalition Summer Conference: Contract Pharmacy Compliance—Oversight by the EntityAugust 2, 20222 minute read
- PublicationsFTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector23 minute read
- EventsAmerican Society for Pharmacy Law: An Overview of Changes to Claw Backs in CMS’ Part D Final Rule2 minute read
- EventsMedication Intelligence Summit 2022: Pharmacy Procurement Trends and GapsJune 7, 20222 minute read
- Firm AnnouncementsChambers USA 2022 Recognizes Epstein Becker Green's Focused Excellence in Core Practice Areas: Distinguished in Healthcare, Labor & Employment, and Litigation4 minute read
- PublicationsCMS Finalizes Changes to Pharmacy DIR in Part D Starting with Contract Year 202414 minute read
- Firm AnnouncementsFifty-Eight Epstein Becker Green Attorneys Recognized for Professional Excellence–Three Attorneys Distinguished as “Lawyer of the Year”–by The Best Lawyers in America 20227 minute read
- Events340B Coalition Summer Conference 2021: Contract Pharmacy Basics1 minute read
- PublicationsFinalized HHS Drug Formulary Rebate Rule Faces Uncertain Future Under Biden Administration and Current Legal Challenge20 minute read
- PublicationsLowering Drug Prices with the Anti-Kickback Statute: Future and Impact of HHS Final Rule to Disrupt Drug Formulary Rebates2 minute read
- Media CoverageAlan Arville Quoted in “340B Provider Camp Cheers HHS Letter to Lilly, Pharma Camp Says the Fight Isn’t Over”2 minute read
- PublicationsPresident Trump Signs Executive Orders on Drug Pricing and Domestic Supply Chain Reform22 minute read
- PublicationsStates Are Questioning Medicaid MCO Rx Benefits3 minute read
- PublicationsA Chance for Pharmacies to Showcase Health Care Services2 minute read
- BlogsFace or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances4 minute read
- EventsAPhA2020: The Drug Cost Controversy, Part 2 – What's Next?1 minute read
- EventsRetail and Specialty Pharmacy: Strategic and Regulatory Considerations for Expanding Hospital Pharmacy Options1 minute read
- PublicationsTelehealth Growth = Expansion of Fraud & Abuse Enforcement2 minute read
- EventsHHS OIG Proposed Rule on the Safe Harbor for Pharmaceutical Rebates: The Issues and Impact2 minute read
- EventsDrug Pricing and Reimbursement: 2018 in Review and Outlook for 20192 minute read
- PublicationsHHS OIG Proposes Anti-Kickback Safe Harbor Amendments to Regulate and Restrict the Provision of Manufacturer Remuneration to Plan Sponsors and PBMs19 minute read
- PublicationsCMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 202028 minute read
- BlogsHRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule3 minute read
- BlogsNew Federal Laws Banning “Gag Clauses” in the Pharmacy4 minute read
- Events340B Drug Pricing Program: Past, Present and Future1 minute read
- BlogsCMS Finalizes Policy and Technical Changes to the Medicare Advantage and Part D Programs for CY 20195 minute read
- Events340B Coalition Winter Conference: Contract Pharmacy Arrangements1 minute read
- BlogsWhite House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices8 minute read
- PublicationsComment Deadline Approaches for CMS's Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 2: Beneficiary Cost, Access, and Protection21 minute read
- BlogsCMS Final Rule Will Reduce Medicare Part B Drug Payments by Nearly 30% for 340B Hospitals5 minute read
- Trends in Drug Pricing and Reimbursement: Thought Leaders in Health Law Video Series
- EventsASPL: 340B Drug Discount Program: Evolving Compliance Standards for Covered Entities and Contract Pharmacies in Wake of Proposed 340B Mega Guidance and Orphan Drug Ruling1 minute read
- PublicationsPaul Gomez, Katherine Lofft, Alan Arville Contributed to AHLA Representing Hospitals and Health Systems Handbook1 minute read
- Events340B Coalition 20th Annual Summer Conference2 minute read
- EventsAHLA Physicians and Hospitals Law Institute2 minute read
- PublicationsCMS Issues Final Rule on Covered Outpatient Drugs38 minute read
- BlogsU.S. District Court Vacates HRSA's Interpretative Rule on Orphan Drugs9 minute read
- Events2015 MDRP Summit: Addressing Key Areas Covered Within the 340B "Omnibus Guidance"1 minute read
- Media CoverageAlan Arville Quoted in "Attorneys Have Concerns with 340B Program Guidance"2 minute read
- BlogsHRSA Issues Proposed "Omnibus Guidance"11 minute read
- Events340B Coalition Annual Conference: Third-Party Billing & Reimbursement Roundtable1 minute read
- Events340B Coalition Annual Conference: Panel for 340B Service Providers1 minute read
- Events340B Coalition Annual Conference: Contract Pharmacy Interest Group1 minute read
- PublicationsHouse Energy and Commerce Committee Proposes, then Drops, 340B Reform Language to 21st Century Cures Legislation1 minute read
- BlogsHouse Energy and Commerce Committee Proposes, then Drops, 340B Reform Language to 21st Century Cures Legislation4 minute read
- PublicationsConstance Wilkinson, Alan Arville Comment on Specialty Drug Cost Upswing2 minute read
- PublicationsMembers of House Subcommittee Express Support for the 340B Program, but Need for Clarity, Oversight and Transparency1 minute read
- BlogsMembers of House Subcommittee Express Support for the 340B Program, but Need for Clarity, Oversight and Transparency6 minute read
- Events340B Coalition Winter Conference1 minute read
- BlogsHRSA Withdraws 340B "Mega-Reg;" Plans to Issue Guidance in 20156 minute read
- EventsHot Topics in Pharmacy Compliance and Enforcement1 minute read
- PublicationsOIG Warns Pharmaceutical Manufacturers of Improper Part D Beneficiary Coupon Use9 minute read
- BlogsHRSA Issues Interpretive Rule on 340b Orphan Drug in Response to Court Vacating Final Rule7 minute read
- Events340B Coalition Conference: 340B Contract Pharmacy Basics1 minute read
- PublicationsCMS Scaled Back Changes to the Medicare Part D Prescription Drug and Medicare Advantage Programs, but Some Important Revisions Remain11 minute read
- EventsHealth Care Transactions: 340B Program Considerations for Acquisitions and Contract Pharmacy Arrangements1 minute read
- EventsStructuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements2 minute read
- PublicationsMore Contract Pharmacy Oversight for HHS 340B Program, inLaw3602 minute read
- BlogsMajor Themes at 340B Coalition Winter Conference Include Contract Pharmacy Oversight, Medicaid Managed Care, and Anticipated 340B "Mega-Reg"7 minute read
- BlogsOIG Issues Report on 340B Contract Pharmacy Arrangements Supporting Need for Tighter Rules6 minute read
- Events340B Coalition Winter Conference: 340B Contract Pharmacies and Pharmacy Service Providers2 minute read
- PublicationsCMS Proposes Far-Reaching Changes to the Medicare Part D Prescription Drug Benefit Program and the Medicare Advantage Program23 minute read
- EventsNCPA 115th Annual Convention: 340B Contracting Essentials and Best Practices1 minute read
- Firm AnnouncementsEpstein Becker Green Expands National Health Care and Life Sciences Practice with Alan J. Arville2 minute read
- Events340B Programs in Disproportionate Share Hospitals: What to Expect and How to Cope With Inquiries from HRSA, Manufacturers, and Senator Grassley1 minute read
- Events340B Basics: An Introduction to 340B Compliance and Contract Pharmacy Arrangements1 minute read
- Events340B Contract Pharmacy Arrangements: A Strafford Publications Webinar1 minute read
- PublicationsImportant Considerations in Negotiating a Managed Care Contract: The Provider Perspective, in BNA's Health Law Resource Center1 minute read